Neuropeptide S: A new player in the modulation of arousal and anxiety

Molecular Interventions

Volumn 5, Issue 1, 2005, Pages 42-46

  Reinscheid, Rainer K ^a   Xu, Yan Ling ^a   Civelli, Olivier ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; COCAINE; G PROTEIN COUPLED RECEPTOR; MODAFINIL; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S; OREXIN; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG;

ANXIETY; ANXIETY DISORDER; AROUSAL; BRAIN REGION; DRUG MECHANISM; DRUG TARGETING; FEAR; HUMAN; HYPERSOMNIA; INSOMNIA; NARCOLEPSY; NEUROMODULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SEDATION; SIDE EFFECT; SLEEP STAGE; SLEEP WAKING CYCLE; STRESS; TRANQUILIZING ACTIVITY;

AMINO ACID SEQUENCE; ANIMALS; ANXIETY; AROUSAL; HUMANS; MOLECULAR SEQUENCE DATA; NERVOUS SYSTEM; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; STRESS;

EID: 16344382552     PISSN: 15340384     EISSN: None     Source Type: Journal    
DOI: 10.1124/mi5.1.8     Document Type: Review

References (29)

1. Marchese, A., George, S.R., Kolakowski, L.F., Lynch, K.R., and O'Dowd, B.F. Novel GPCRs and their endogenous ligands: Expanding the boundaries of physiology and pharmacology. Trends Pharmacol. Sci. 20, 370-375 (1999).
2. Civelli, O., Nothacker, H.P., Saito, Y., Wang, Z., Lin, S., and Reinscheid R.K. Discovery of novel neurotransmitters as natural ligands of orphan G protein-coupled receptors. Trends Neurosci. 24, 230-237 (2001).
3. Drews, J. Drug discovery: A historical perspective. Science 287, 1960-1964 (2000).
4. Jones, B.E. Arousal systems. Frontiers in Bioscience 8, 438-451 (2003).
5. Aston-Jones, G. and Bloom, F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1, 876-886 (1981).
6. Aston-Jones, G., Rajkowski, J., Kubiak, P., Valentino, R.J. and Shipley, M.T. Role of the locus coeruleus in emotional activation. Prog. Brain Res. 107, 379-402 (1996).
7. Berridge, C.W. and Foote, S.L. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J. Neurosci. 11, 3135-3145 (1991).
8. Bremner, J.D., Krystal, J.H., Southwick, S.M., and Charney, D.S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23, 28-38 (1996).
9. Rizvi, T.A., Ennis, M., Aston-Jones, G., Jiang, M., Liu, W.L., Behbehani, M.M., and Shipley, M.T. Preoptic projections to Barrington's nucleus and the pericoerulear region: Architecture and terminal organization. J. Comp. Neurol. 347, 1-24 (1994).
10. Swanson, L.W. and Hartman, B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J. Comp. Neurol. 163, 467-505 (1975).
11. Swanson, L.W., Sawchenko, P.E., Rivier, J., and Vale, W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36, 165-186 (1983).
12. Sved, A.F., Cano, G., Passerin, A.M., and Rabin BS. The locus coeruleus, Barrington's nucleus, and neural circuits of stress. Physiol. Behav. 77, 737-742 (2002).
13. Sakurai, T., Amemiya, A., Ishii, M. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573-585 (1998).
14. Sakurai, T. Reverse pharmacology of orexin: From an orphan GPCR to integrative physiology. Regul. Pept. 126, 3-10 (2005).
15. Nishino, S., Ripley, B., Overeem, S., Lammers, G.J., and Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 b, 39-40 (2000).
16. Lin, L., Faraco, J., Li, R. et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365-376 (1999).
17. Chemelli, R.M., Willie, J.T., Sinton, C.M. et al. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 98, 437-451 (1999).
18. Peyron, C., Tighe, D.K., van den Pol, A.N., de Lecea, L., Heller, H.C., Sutcliffe, J.G., and Kilduff, T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996-10015 (1998).
19. Date, Y., Ueta, Y., Yamashita, H., Yamaguchi, H., Matsukura, S., Kangawa, K., Sakurai, T., Yanagisawa, M., and Nakazato, M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. USA 96, 748-753 (1999).
20. Nambu, T., Sakurai, T., Mizukami, K., Hosoya, Y., Yanagisawa, M., and Goto, K. Distribution of orexin neurons in the adult rat brain. Brain Res. 827, 243-260 (1999).
21. Cirelli, C., Pompeiano, M., and Tononi, G. Neuronal gene expression in the waking state: a role for the locus coeruleus. Science 274, 1211-1215 (1996).
22. Hunsley, M.S. and Palmiter, R.D. Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine. Sleep 26, 521-526 (2003).
23. Xu, Y.L., Reinscheid, R.K., Huitron-Resendiz, S.et al. Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43, 487-497 (2004).
24. Hascoet, M. and Bourin, M. A new approach to the light/dark test procedure in mice. Pharmacol. Biochem. Behav. 60, 645-653 (1998).
25. Paine, T.A., Jackman, S.L., and Olmstead, M.C. Cocaine-induced anxiety: Alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. Behav. Pharmacol. 13, 511-523 (2002).
26. Hagan, J.J., Leslie, R.A., Patel, S. et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA 96, 10911-10916 (1999).
27. Bourgin, P., Huitron-Resendiz, S., Spier, A.D., Fabre, V., Morte, B., Criado, J.R., Sutcliffe, J.G., Henriksen, S.J., and de Lecea, L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci. 20, 7760-7765 (2000).
28. Simon, P., Panissaud, C., and Costentin, J. The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine. Psychopharmacology 114, 597-600 (1994).
29. Chaouloff, F., Durand, M., and Mormede, P. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests. Behav. Brain Res. 85, 27-35 (1997).